Stada has a majority stake in Bioceuticals

Germany’s Stada says it is “increasing its presence in the important biosimilar sector” by entering into a deal to take a controlling stake in local biologic ingredients manufacturer Bioceuticals. The company “manufactures the active ingredient erythropoietin and markets it [via] sales licences to Stadapharm and other third parties”, Stada noted.

“Subject to approval by the antitrust authorities, Stada is acquiring an additional 35.48% of the shares from its co-shareholders, which...